The Operating System for Clinical Operations
Unify trial oversight, CRO accountability, and risk visibility in one supervised execution layer.
A Day in the Life of a VP Clinical Operations
The day begins before the inbox is opened. Twelve trials are running across four CROs, two safety vendors and a global site network. By breakfast there is a missed monitoring visit, a delayed IRB submission, an enrollment slip in APAC and a board update due by Friday.
Every conversation through the day is the same shape — chasing status, reconciling versions, escalating coordination. The systems show what is happening. They do not change what is happening.
The constraint is no longer visibility. It is execution capacity. That is exactly where Maxis AI starts working.
Human-in-the-loop validation · Audit traceability · Governed execution
The Pressures VPs of Clinical Operations Carry Every Day
Volume Without Headcount
Trial volume and protocol complexity are growing faster than teams can be hired or trained — execution capacity becomes the binding constraint.
Coordination Overhead
Operations leaders spend their day across CROs, vendors, sites and internal functions — the work is mostly coordination, not decisions.
Reactive Risk Posture
Risks are detected earlier than ever, but resolution is still manual. By the time mitigation runs, milestones have already slipped.
Operations doesn't need more dashboards. It needs governed execution capacity.
Industry Reality
- Digital platforms have improved monitoring — they have not increased throughput.
- Clinical development remains labor-bound; growth still maps to headcount.
- Most AI pilots stop at insight; few reach validated, production execution.
- Inspection-readiness expectations continue to rise across regions.
- Vendor and CRO portfolios fragment ownership and slow accountability.
Operations is being asked to do more, faster, with the same teams — under stricter governance.
How Maxis AI Is Built for Clinical Operations
Maxis AI deploys an AI workforce of supervised agents that execute clinical operations work — not just describe it. Agents draft IRB packages, coordinate site activation, track enrollment signals, run reconciliations and prepare oversight outputs.
Every action is logged with full context. Human reviewers retain approval authority. Execution is governed end-to-end under GxP, 21 CFR Part 11, ICH-GCP and SOC 2 Type II controls.
The result is the same operations leadership, scaled — without proportional headcount growth.
From Pain to Outcome: How Maxis AI Works for You
Pain Point
AI Capability
Outcome
Prolonged IRB drafting and revision cycles delay startup.
Protocol-aware IRB drafting and submission coordination agents.
Compressed startup timelines with standardized submission quality.
Fragmented oversight across EDC, CTMS and eTMF.
Cross-system execution layer with unified action logs.
Single, traceable view of execution across studies.
Reactive risk detection after milestone slippage.
Continuous monitoring agents with structured intervention.
Earlier detection with governed, repeatable response.
Escalation-heavy coordination across vendors and sites.
Agent-driven coordination workflows with audit trails.
Reduced escalation load on senior operations leaders.
Enrollment forecasting variability disrupts planning.
Continuous enrollment signal tracking and structured forecasting support.
Improved milestone predictability across portfolios.
Recovered 30% Enrollment Gap in 8 Weeks, Avoiding ~6-Month Trial Delay
Discover how a clinical operations leader improved site performance visibility across US and EU trials, detected enrollment decline earlier, and reduced the risk of trial delays driven by late intervention.
38%
Faster Startup
2.4x
Coordination Throughput
100%
Audit Traceability
0
System Replacements
All You Need to Know
CTMS and eTMF record what happened. Maxis AI executes the work — drafting, coordinating, reconciling and monitoring — under supervision, with every action logged back into your existing systems.
No. Maxis AI operates as a governed execution layer over EDC, CTMS, safety, imaging and eTMF. There is no rip-and-replace.
Every agent action runs inside defined guardrails with human-in-the-loop checkpoints. Reviewers retain approval authority across all governed actions.
No. It removes coordination overhead so leaders focus on judgment, escalation and strategy.
Startup predictability, enrollment coordination and reduced escalation overhead are typically the earliest signals.
Explore the Agentic AI Platform.
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.